A phase 1/2a study to test the safety and immunogenicity of a p16INK4a peptide vaccine in patients with advanced human papillomavirus-associated cancers - Reuschenbach, Miriam; Kloor, Matthias; Prigge, Elena-Sophie; Sauer, Madeleine; Knebel Doeberitz, Magnus von (Cancer, 2016)
Gesehen am 18.10.2019